News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Business
Pheromone Sciences Corp. Builds Scientific Advisory Board: Sertoli Cell Expert Dr. Jannette Dufour To Help Develop Diabetes Product
August 1, 2006
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
Pheromone Sciences Corp. ("Pheromone") (TSX VENTURE: PHS) is pleased to announce that Dr. Jannette Dufour, PhD has joined its Scientific Advisory Board ("SAB") to assist the company with its diabetes product development.
Twitter
LinkedIn
Facebook
Email
Print
People
MORE ON THIS TOPIC
Mergers & acquisitions
Roche Makes Major MASH Move With $3.5B 89bio Buy
September 18, 2025
·
2 min read
·
Tristan Manalac
Layoff Tracker
Arsenal, X4 Lay Off Half of Staff to Cut Costs
September 18, 2025
·
201 min read
·
BioSpace Editorial Staff
CDC
Republicans Ratchet Up Pressure as Monarez Levels Damning Allegations Against Kennedy
September 17, 2025
·
4 min read
·
Heather McKenzie
Layoffs
Innate Sheds 30% of Staff, Narrows Pipeline Focus Amid ‘Challenging Funding Environment’
September 17, 2025
·
1 min read
·
Tristan Manalac